Resultados de Búsqueda

Evidencias COVID-19

IHCAI – DIME. Información seleccionada sobre intervenciones para el tratamiento de COVID-19

The potential role of a series of public health measures, called non-pharmaceutical interventions (NPI), aimed at reducing contact rates in the population and therefore reducing transmission of the virus, is evaluated. As the conclusion of this report, the effectiveness of any isolated intervention may be limited, requiring multiple interventions to be combined to have a substantial impact on transmission. Two fundamental strategies are proposed: (a) mitigation, which focuses on slowing down, ...

Evidencias COVID-19

IHCAI – DIME. Información seleccionada sobre intervenciones para el tratamiento de COVID-19

Regarding the information that has emerged about the danger of using ibuprofen in COVID-19 infections, it is wanted to communicate that the World Health Organization (WHO) and some Regulatory Authorities such as the European Medicines Agency (EMA), the NHS of the United Kingdom, the AEMPS in Spain and the HPRA in Ireland have stated that there is currently no evidence to confirm an aggravation of COVID-19 infection with ibuprofen or other NSAIDs. The EMA even recommends that when starting fever ...

Evidencias COVID-19

IHCAI – DIME. Información seleccionada sobre intervenciones para el tratamiento de COVID-19

This systematic review does not have quantitative analysis, it is narrative, the authors define the purpose and findings as follows: "Purpose: COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. From this Currently, there is no known effective pharmaceutical treatment, although it is very necessary for the patient to contract the severe form of the disease.The objective of this systematic review was to summarize the evidence regarding chloroquine for the ...

Evidencias COVID-19

IHCAI – DIME. Información seleccionada sobre intervenciones para el tratamiento de COVID-19

The question was raised whether the BCG vaccine would also affect the spread of the disease, with the caveat that the number of reported cases of COVID-19 will largely depend on the number of tests conducted by country. Upper and upper middle income countries that have a current universal BCG policy (55 countries) had 59.54 ± 23.29 (average ± s.e.m) cases per million inhabitants. Consistent with BCG's role in slowing the spread of COVID - 19, upper middle and upper income countries that never ...

Evidencias COVID-19

IHCAI – DIME. Información seleccionada sobre intervenciones para el tratamiento de COVID-19

A cross-sectional observational study was carried out, which included 10 patients diagnosed with severe COVID-19, from different hospitals in China. After convalescent plasma (CP) transfusion, the level of neutralizing antibodies increased rapidly in five cases. Clinical symptoms improved significantly along with the increase in oxyhemoglobin saturation in 3 days. Several parameters tended to improve compared to pre-transfusion, including increased lymphocyte count (0.65 × 109 / L vs. 0.76 × ...